Hedge Fund - MIC Capital Partners

Mubadala Capital Bio, Returns, AUM, Net Worth

MIC Capital Partners III, managed by Mubadala Investment Company, is a buyout fund headquartered in Abu Dhabi, United Arab Emirates. Specializing in investments across Europe and North America, the fund targets sectors including media, sports, entertainment, consumer goods, food service, financial services, industrial, and business services.

Mubadala Capital, the wholly-owned asset management subsidiary of Mubadala Investment Company, oversees approximately $20 billion in assets under management, including $13 billion in third-party capital vehicles. Established in 2011, Mubadala Capital operates four integrated businesses: Private Equity, Venture Capital, Alternative Solutions, and a Brazil-focused investment arm. Each business employs a fundamental-driven investment strategy prioritizing capital preservation and downside protection.

In addition to managing its balance sheet investments, Mubadala Capital oversees approximately $13 billion in third-party capital vehicles across its diverse portfolio. This includes four flagship private equity funds, three early-stage venture funds, two specialized funds in Brazil, and a diversified evergreen investment strategy focused on private market opportunities. The firm also manages a range of co-investment vehicles, SPVs, and continuation funds. Mubadala Capital invests across the capital structure, both in private and public securities, aiming for a well-diversified portfolio that delivers superior risk-adjusted returns for its shareholders and investors. As a distinctive and value-added investor, Mubadala Capital leverages its global reach to source proprietary investment opportunities and actively utilizes the Mubadala network to enhance its business operations.

Mubadala Capital
Fund Profile
Filing Period:
Fund Name: MIC Capital Partners
Manager Mubadala Capital
Portfolio Value $720,075,298
Change This QTR +1.57%
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1. EDR 8,536,456 $243,801,183 33.85%
2. HAYW 11,764,660 $180,469,884 NEW 25.06%
3.
Neumora Therapeutics Inc.
4,460,700 $58,925,848 8.18%
4. RXRX 8,451,758 $55,697,086 7.73%
5. CPNG 1,412,946 $34,687,824 4.81%